Last reviewed · How we verify

NCT06040008: IMEN

Investigating the Impact of Environmental Factors on the Transcriptomics Profile in Healthy Individuals

Completed Last updated 20 September 2024
What this trial tests

trial testing blood collection in Healthy Volunteers in 8 participants. Completed in 29 February 2024.

Timeline
9 May 2023
Primary endpoint
29 February 2024
29 February 2024

Quick facts

Lead sponsorCENTOGENE GmbH Rostock
StatusCompleted
Study typeOBSERVATIONAL
Enrollment8
Start date9 May 2023
Primary completion29 February 2024
Estimated completion29 February 2024
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

CENTOGENE GmbH Rostock

Who can join

18 and older, any sex, with Healthy Volunteers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Changes in biology will be reflected by changes in the composition of Ribonucleic acid (RNA) in the blood. An example of that would be environmental changes, e.g. diet, acute illness, temperature. The main goal of this study is to study the impact of environmental changes in blood transcriptomics in healthy individuals over time.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of blood collection

Trials testing the same drug.

Other recruiting trials for Healthy Volunteers

Currently open trials in the same condition.

Other CENTOGENE GmbH Rostock trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06040008.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing